November 18th 2024
AHA 2024. Findings from the BPROAD trial help fill a gap left by similar studies on the ideal target SBP for adults with type 2 diabetes, said study authors.
November 15th 2024
Aprocitentan is the first-and-only dual endothelin receptor antagonist approved for the treatment of systemic hypertension.
September 27th 2024
Your daily dose of the clinical news you may have missed.
September 25th 2024
September 17th 2024
New data shows that favorable CV health in the first trimester is associated with a 35% to 62% lower risk of HDP regardless of level of genetic risk.
Hypertension-related CVD Most Common ED Presentation in the US
Approximately one-third of CV-related ED visits are for hypertension-related conditions, including 13% for essential hypertension among women.
Nocturnal Hypertension: 8 Essential Questions
Nocturnal HTN is a risk factor for cardiovascular disease and stroke. How do you diagnose and treat in your practice? Test your overnight BP IQ.
Cumulative Load of Systolic BP May Better Predict CV Risk in T2D Patients vs Standard BP Measures
In patients with type 2 diabetes, for every standard deviation increase in cumulative SBP load there was an increase of at least 10% in CV risk, a new study found.
Urban Areas in US are Associated with Lower Rates of Hypertension Medication Adherence, New Study Finds
AHA Hypertension 2022: New research showed that hypertension medication adherence was nearly 76% in large urban areas and increased as population density decreased.
Hypertension Treatment is Cost-effective for CVD Prevention, Whether the Target is from ACC/AHA or JNC 7, Study Reveals
Reducing blood pressure to 140/90 mm Hg or 130/80 mm Hg in high-risk patients proved either cost-saving or cost-effective at 10 years in a simulation study.
DASH Diet May Prevent Nearly 27 000 US CVD Events in Patients with Stage 1 Hypertension, According to Simulation Study
AHA Hypertension 2022: Adoption of the DASH diet was found to prevent an estimated 16 000 CVD events among men and 11 000 among women with untreated stage 1 HTN.
Education on Use of ABPM Data Needed in Primary Care to Avoid Misdiagnosis of Hypertension
AHA Hypertension 2022. Half of patients with newly elevated BP had white coat HTN yet some were diagnosed with HTN at next primary care visit, new study finds.
Hypertension Awareness and Control Improved with Better Access to Primary Care, New Study Finds
Regardless of where individuals live, they may benefit from blood pressure control programs that increase access to primary health care, study authors suggest.
DASH Diet, Weight Loss, Exercise and Other Nondrug Strategies to Manage Hypertension
Find out how effective these 3 and 5 additional ACC/AHA-recommended non-drug interventions are at reducing BP (in mm Hg) in adults with hypertension and with normal BP.
High HDL-C Increases CV Risk in Men with Hypertension, Study Finds
In patients with hypertension, HDL-C >80 mg/dL was linked to a greater risk for CV events among men but not among women. Protective?
Specific Blood Pressure Thresholds Not Needed When Selecting Patients with T2D for Antihypertensive Treatment, Suggests New Research
Blood pressure-lowering therapy reduced the risk of major CV events in persons with and without type 2 diabetes, according to an individual participant-level data meta-analysis.
8 Key Drivers of Hypertension Control & How to Improve Them
These 8 drivers of BP control reflect study of high-performing health systems and the strategies that have led to successful large scale hypertension management.
Seen in the ED: Diarrhea and BUQ Pain
The woman is in her mid-fifties, diarrhea has been persistent for 10 days and BUQ pain for 2 days. What does the CT show? What's your diagnosis?
Self-measured BP Using Smartphone App No More Effective than Using Standard Device to Reduce Hypertension
Blood pressure reduction of approximately 11 mm Hg was seen at 6 months regardless of device used, suggesting patients can keep SMBP simple.
Salt Substitutes Lower BP, Reduce Risk of Cardiovascular, All-cause Mortality Across Patients, Borders
Meta-analysis authors say the significant preventive effects of replacing use of salt with salt substitutes have important worldwide public health implications.
Age at Hypertension Diagnosis Younger for US Black, Hispanic Adults
Earlier age at hypertension onset could lead to greater cumulative exposure to elevated BP, exposure known to increase risk of CVD and that could lead to disparities in outcomes.
USPSTF Issues Recommendations on Lifestyle Change Counseling to Prevent CVD
The USPSTF guidance supports shared decision making with patients without CVD risk factors who may benefit from behavioral counseling on diet and physical activity.
Risk of MCI Progression to Dementia Reduced with ARBs vs Other Hypertension Rx
A new study compared the differential effects of agents used to treat hypertension on the risk for dementia in patients with hypertension and mild cognitive impairment.
Chronic Kidney Disease Present in 1 in 10 Adults: Study of 2.4 Million People in 11 Countries
Chronic kidney disease is underdiagnosed and undertreated across major Western countries, according to findings of the new CaReMe CKD study.
11 Cardiology Highlights for Primary Care, January to June, 2022
These 11 studies of cardiovascular and metabolic disease prevention, assessment, and treatment were top trending topics on Patient Care in the first half of 2022.
Salt Added Frequently to Food May Increase Risk for Premature Mortality: Study
Adding salt regularly to food after cooking/preparation may increase risk of premature death by up to 28% and reduce life expectancy by an average of 2 years.
US Cardiometabolic Health in Steady Decline, Racial/Ethnic Minorities at High Risk
Less than 7% of the US population has "optimal" cardiometabolic health, with declines over 20 years significantly affecting racial/ethnic populations.
Stroke Patients Very Likely to Present with Undiagnosed Risk Factors
Three-quarters of stroke patients in a Swiss registry had at least 1 undiagnosed risk factor at the time of the event, most commonly hyperlipidemia or hypertension.
American Heart Association Announces "Life's Essential 8" Enhanced Cardiovascular Health Model
Slide Show: The AHA added sleep duration to its Life's Simple 7 cardiovascular health construct and updated sections on diet, lipids, blood glucose and smoking.
Time to Benefit Following Intensive BP Reduction in Adults Aged 60 Years and Older
The first study of its kind found that intensive blood pressure control may be most beneficial in older adults with life expectancy greater than 3 years vs less than 1 year.
National Kidney Foundation Urges USPSTF to Prioritize Screening Recommendation for CKD
The USPSTF is rumored to have moved screening for chronic kidney disease to a preventive service it is actively considering and the NFK says, "It's time."
Time at Target Blood Pressure Significantly Increased with Triple Combination Pill
Patients who received a low-dose 3-drug combination pill achieved time at BP target of 64% vs the usual care group result of 43% in a post-hoc analysis of TRIUMPH.
Antihypertensive Treatment during Pregnancy Linked to Better Outcomes, According to New NIH Study
ACC 2022: Use of antihypertensive therapy in pregnant women was associated with better pregnancy outcomes, such as preeclampsia and fetal or neonatal death.
Popular Hypertension-related Videos on TikTok Often Not Backed by Medical Literature, Found New Study
ACC 2022. Study assessed hypertension-related TikTok videos and found that 42% addressed alternative medicine, more than twice the number that focused on medical treatments.
Empagliflozin CKD Phase 3 Trial Stopped Early for Positive Efficacy Seen in Interim Assessment
The phase 3 EMPA-KIDNEY clinical trial had just met prespecified criteria for positive efficacy when the study's Independent Data Monitoring Committee recommended the early halt.